You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RGNT Award Disclosure
Cohen Arazi Efraim · SEC Form 4 · Filed Jul 13, 2026
Award
Calculated transaction value
$0
Cohen Arazi Efraim Director
RGNT
Transaction date
Jul 9, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 4 days later
RGNT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 24,826 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-077622
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regentis Biomaterials Ltd. RGNT Current | Award | Jul 9, 2026 | $0 |